Product description

Insulin glargine. 

Dosage form: solution for subcutaneous injections in 3 ml cartridges and pre-filled disposable insulin pen.

·         Long-acting basal insulin
·         Maintains normal physiologic concentration of basal (background) insulin
·         Most widely used basal insulin analogue. Is the reference product for all basal insulins.
·         Increased duration of action of insulin glargine is associated with subcutaneous microprecipitate generation from which small amounts of insulin glargine permanently release, which makes it possible to administer the product once a day.
·         Concentration: U100
·         Onset of action after subcutaneous administration – in 1 hour
·         29 hours – maximum action
·         24 hours – duration of action

Read more

Specifications

Categories Biopharmaceuticals; BiopharmaceuticalsBiosimilars
Sales markets Middle East Region (e.g. UAE); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from Russian Federation

More products from Geropharm

Spring-free simplicity for higher volumes: the new UniSafe®️ safety device for 2.25mL prefilled syringes

Spring-free simplicity for higher volumes: the new UniSafe®️ s...

DISSOLUTION OF OIL SOFT GELATIN CAPSULES FROM FORMULATION TO ANALYTICAL DEVELOPMENT

DISSOLUTION OF OIL SOFT GELATIN CAPSULES FROM FORMULATION TO A...

Tjoapack

Tjoapack

Jiudian Pharmaceutical welcome your communication!

Jiudian Pharmaceutical welcome your communication!

Marchesini Group, Packaging Solutions

Marchesini Group, Packaging Solutions